Changes in SARS-CoV-2 spike versus nucleoprotein antibody responses impact the estimates of infections in population-based seroprevalence studies

…, F Pojer, C André, C Pellaton, A Farina… - Journal of …, 2021 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibody responses
to the spike (S) protein monomer, S protein native trimeric form, or the nucleocapsid (N) …

A high-throughput cell-and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma

C Fenwick, P Turelli, C Pellaton, A Farina… - Science Translational …, 2021 - science.org
The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific
antibodies in the serum of an individual indicates previous infection or vaccination. However, …

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys

…, L Esteves-Leuenberger, J Campos, A Farina… - Nature …, 2022 - nature.com
The SARS-CoV-2 Omicron variant has very high levels of transmission, is resistant to
neutralization by authorized therapeutic human monoclonal antibodies (mAb) and is less sensitive …

CD160-associated CD8 T-cell functional impairment is independent of PD-1 expression

…, R Banga, F Bellanger, C Pellaton, A Farina… - PLoS …, 2014 - journals.plos.org
Expression of co-inhibitory molecules is generally associated with T-cell dysfunction in
chronic viral infections such as HIV or HCV. However, their relative contribution in the T-cell …

[PDF][PDF] A highly potent antibody effective against SARS-CoV-2 variants of concern

…, L Perez, C Pellaton, L Esteves-Leuenberger, A Farina… - Cell Reports, 2021 - cell.com
Control of the ongoing SARS-CoV-2 pandemic is endangered by the emergence of viral
variants with increased transmission efficiency, resistance to marketed therapeutic antibodies, …

Large TCR diversity of virus-specific CD8 T cells provides the mechanistic basis for massive TCR renewal after antigen exposure

I Miconnet, A Marrau, A Farina, P Taffé… - The Journal of …, 2011 - journals.aai.org
Ex vivo analysis of virus-specific CD8 T cell populations by anchored PCR has shown that
the CD8 TCR repertoire was less oligoclonal (seven to nine clonotypes per individual epitope…

Tumor suppression of novel anti–PD-1 antibodies mediated through CD28 costimulatory pathway

…, V Joo, C Pellaton, A Farina… - Journal of Experimental …, 2019 - rupress.org
Classical antagonistic antibodies (Abs) targeting PD-1, such as pembrolizumab and
nivolumab, act through blockade of the PD-1–PDL-1 interaction. Here, we have identified novel …

Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys

…, J Campos, L Esteves-Leuenberger, A Farina… - Journal of Infection, 2023 - Elsevier
Objectives Due to the rapid evolution of SARS-CoV-2 to variants with reduced sensitivity to
vaccine-induced humoral immunity and the near complete loss of protective efficacy of …

[PDF][PDF] Game-Theoretic Decision Making in Imperfect-Information Games

G Farina - 2020 - csd.cmu.edu
Designing machines that can reason strategically and make optimal decisions even in the
presence of imperfect information and adversarial behavior is a fundamental goal of artificial …

SARS-CoV-2 Omicron potently neutralized by a novel antibody with unique Spike binding properties

…, C Raclot, L Esteves-Leuenberger, J Campos, A Farina… - bioRxiv, 2022 - biorxiv.org
The SARS-CoV-2 Omicron variant exhibits very high levels of transmission, pronounced
resistance to authorized therapeutic human monoclonal antibodies and reduced sensitivity to …